The synthesis and receptor binding affinities of DDD-016, a novel, potential, atypical antipsychotic†
Abstract
A new pentacyclic compound, DDD-016 (10d) was designed and synthesized as a potential antipsychotic and screened for binding affinity in a broad panel of over 80 CNS and other receptors,